Literature DB >> 8172999

Epidemiology of pelvic inflammatory disease.

F Grodstein1, K J Rothman.   

Abstract

The epidemiologic study of pelvic inflammatory disease (PID) is hindered by symptoms that differ substantially from case to case, and by a substantial number of "silent" cases with few or no symptoms. Demographic data indicate that PID is primarily a disease of the young. Race also appears to be a determinant, but whether for biologic or sociologic reasons is not known. Women who are not married face a greater risk for PID than married women. The majority of PID cases are associated with sexually transmitted diseases. Consistent with this finding is the pattern of risk factors related to sexual behavior: young age at first intercourse, high frequency of intercourse, and a large number of sexual partners all increase the risk of PID. On the other hand, barrier methods of contraception appear to reduce the risk of PID, as does oral contraception. Perhaps the best publicized risk factors for PID is another contraceptive, the intrauterine device (IUD). The increased risk of PID in IUD users appears to be confined to new users and women at high risk of sexually transmitted disease infection. Douching and cigarette smoking may also be associated with the development of PID, but the evidence is weak.

Entities:  

Mesh:

Year:  1994        PMID: 8172999     DOI: 10.1097/00001648-199403000-00014

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  11 in total

Review 1.  Pelvic inflammatory disease.

Authors:  J Ross
Journal:  BMJ       Date:  2001-03-17

Review 2.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

3.  Influence of material deprivation on hospital admissions for gynaecologic infections.

Authors:  B Olowokure; J I Hawker; S Harcourt; F Warburton; J Weinberg; R C Wilson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-25       Impact factor: 3.267

Review 4.  Pelvic inflammatory disease.

Authors:  Jonathan D C Ross
Journal:  BMJ Clin Evid       Date:  2013-12-11

5.  Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the United States, 1995 and 2006-2010.

Authors:  Jami S Leichliter; Anjani Chandra; Sevgi O Aral
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

6.  Infection of human fallopian tube epithelial cells with Neisseria gonorrhoeae protects cells from tumor necrosis factor alpha-induced apoptosis.

Authors:  Priscilla Morales; Paz Reyes; Macarena Vargas; Miguel Rios; Mónica Imarai; Hugo Cardenas; Horacio Croxatto; Pedro Orihuela; Renato Vargas; Juan Fuhrer; John E Heckels; Myron Christodoulides; Luis Velasquez
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 7.  Pelvic inflammatory disease.

Authors:  Jonathan D C Ross
Journal:  BMJ Clin Evid       Date:  2008-03-10

8.  Expression of proinflammatory cytokines and receptors by human fallopian tubes in organ culture following challenge with Neisseria gonorrhoeae.

Authors:  Kevin Maisey; Gino Nardocci; Monica Imarai; Hugo Cardenas; Miguel Rios; Horacio B Croxatto; John E Heckels; Myron Christodoulides; Luis A Velasquez
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Neisseria gonorrhoeae Challenge Increases Matrix Metalloproteinase-8 Expression in Fallopian Tube Explants.

Authors:  Natalia E Juica; Paula I Rodas; Paula Solar; Paula Borda; Renato Vargas; Cristobal Muñoz; Rodolfo Paredes; Myron Christodoulides; Luis A Velasquez
Journal:  Front Cell Infect Microbiol       Date:  2017-09-06       Impact factor: 5.293

Review 10.  Pelvic inflammatory disease: improving awareness, prevention, and treatment.

Authors:  Breanne B Das; Jocelyn Ronda; Maria Trent
Journal:  Infect Drug Resist       Date:  2016-08-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.